'Sympathy goes out to anyone who lost loved ones,' says AstraZeneca on Covishield row
The admission came a day after the pharma giant admitted in a UK court that its COVID-19 vaccine sold globally as Covishield and Vaxzevria may cause Thrombocytopenia Syndrome (TTS) in "very rare cases".
United Kingdom Adar Serum Institute Of India World Health Organisation United Kingdom Headquartered Thrombocytopenia Syndrome Adar Poonawalla Led Serum Institute
Source: businesstoday.in